GlassScriptPhysician profile
Heather Poppell
NPI 1184281057
$8,471.84
in general payments reported to CMS, 2019-2025
44 companies · $1,943 in 2025
The $1,943 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,418 · 2022: $1,340 · 2023: $1,828 · 2024: $1,942 · 2025: $1,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,686 · Education: $27.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,685.97 |
| Education | $27.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,742.99 | 2021-2025 | Biktarvy |
| Viiv Healthcare Company | $974.48 | 2021-2025 | Dovato, Rukobia |
| Merck Sharp & Dohme LLC | $719.53 | 2021-2025 | Zerbaxa, Dificid, Recarbrio |
| Theratechnologies INC. | $626.60 | 2021-2025 | Trogarzo, Egrifta |
| Averitas Pharma INC. | $592.98 | 2024-2025 | Qutenza |
| Aimmune Therapeutics, INC. | $519.00 | 2023-2025 | Vowst, Zenpep |
| Paratek Pharmaceuticals, INC. | $383.56 | 2021-2025 | Nuzyra |
| Insmed, INC. | $363.61 | 2023-2025 | Arikayce, Brinsupri |
| Janssen Biotech, INC. | $296.95 | 2021-2023 | Symtuza |
| Abbvie INC. | $214.16 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $193.70 | 2021-2022 | |
| Smith+Nephew, INC. | $182.95 | 2022-2025 | Collagenase Santyl, Renasys Touch, Regranex |
| Takeda Pharmaceuticals U.S.A., INC. | $182.36 | 2021-2025 | Cuvitru, Hyqvia |
| Mimedx Group, INC. | $158.83 | 2024-2025 | |
| Melinta Therapeutics, LLC | $143.25 | 2021-2025 | Kimyrsa, Vabomere, Rezzayo |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $130.44 | 2021 | |
| Pfizer INC. | $95.72 | 2021-2022 | |
| Next Science LLC | $94.28 | 2023-2024 | Surgx, Blastx, Xperience |
| Convatec INC. | $80.49 | 2023-2025 | |
| Shionogi INC | $78.96 | 2021-2025 | Fetroja |
| Kci USA, INC. | $56.87 | 2022-2023 | Activ.A.C., Promogran Prisma, V.A.C. Dermatac |
| Mayne Pharma Commercial LLC | $55.50 | 2021-2022 | |
| Bioventus LLC | $54.74 | 2022 | |
| Ferring Pharmaceuticals INC. | $43.84 | 2022-2025 | Rebyota |
| Csl Behring | $42.02 | 2024-2025 | Hizentra |
| Acera Surgical, INC. | $41.85 | 2022 | |
| Medtronic, INC. | $35.81 | 2021 | |
| Kerecis Limited | $31.90 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $31.75 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tactile Systems Technology INC | $30.37 | 2025 | Nimbl, Flexitouch Plus |
| Cumberland Pharmaceuticals, INC. | $30.17 | 2025 | Vibativ |
| Reprise Biomedical, INC. | $27.81 | 2025 | Miro3d |
| Medline Industries LP | $23.03 | 2021 | |
| Grt US Holding, INC. | $22.81 | 2022 | |
| Urgo Medical North America, LLC | $20.17 | 2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Cipher Pharmaceuticals US LLC | $19.07 | 2025 | Spinosad, Natroba |
| Cgg Medical INC | $18.77 | 2021 | |
| Hydrofera LLC | $17.71 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.59 | 2024 | Xifaxan |
| Electromed, INC. | $17.38 | 2021 | |
| Solventum Corporation | $15.46 | 2024 | V.A.C. Dermatac, Activ.A.C. |
| Hartmann USA, INC. | $14.71 | 2021 | |
| Lifenet Health | $14.11 | 2023 | |
| Emd Serono, INC. | $13.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Poppell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.